Masahiro Sekiguchi Selected Research

Masahiro Sekiguchi Research Topics

Disease

8	Neoplasms (Cancer) 06/2023 - 03/2006
7	Rheumatoid Arthritis 05/2019 - 01/2011
5	Fever (Fevers) 05/2022 - 01/2011
4	Neuroblastoma 11/2022 - 03/2019
3	Inflammation (Inflammations) 05/2019 - 03/2006
2	Heart Failure 08/2023 - 05/2023
2	Leukemia 01/2022 - 04/2021
2	Tuberculosis (Tuberculoses) 11/2021 - 01/2011
2	Systemic Scleroderma (Systemic Sclerosis) 01/2017 - 01/2011
2	Polymyositis 01/2017 - 01/2016
2	Arthritis (Polyarthritis) 01/2015 - 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 04/2024
1	Body Weight (Weight, Body) 08/2023
1	Residual Neoplasm 06/2023
1	Thrombosis (Thrombus) 02/2023
1	Myocardial Infarction 02/2023
1	Chest Pain (Chest Pains) 02/2023
1	Acute Coronary Syndrome 02/2023
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2023
1	Kidney Diseases (Kidney Disease) 11/2022
1	Lymphoma (Lymphomas) 10/2022
1	Edema (Dropsy) 07/2022
1	Neoplasm Metastasis (Metastasis) 07/2022
1	Carcinoma (Carcinomatosis) 07/2022
1	Synovitis 07/2022
1	Myocarditis (Carditis) 05/2022
1	Granuloma 11/2021
1	Lymphadenitis (Adenitis) 11/2021
1	Infections 11/2021
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 10/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2021
1	Disease Progression 04/2021
1	Pneumonia (Pneumonitis) 09/2019
1	Cough 09/2019
1	Neutropenia 09/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2019
1	Reinfection 09/2019
1	Pain (Aches) 02/2018
1	Pancreatoblastoma 01/2018
1	Hypersensitivity (Allergy) 01/2018

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 01/2010
3	AntibodiesIBA 11/2021 - 01/2016
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 03/2012 - 03/2006
2	Complement System Proteins (Complement)IBA 06/2023 - 11/2022
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 10/2022 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2019
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 03/2019
2	C-Reactive ProteinIBA 09/2019 - 01/2015
2	Antirheumatic Agents (DMARD)IBA 05/2019 - 11/2016
2	Abatacept (Orencia)FDA Link 05/2019 - 11/2016
2	CollagenIBA 01/2018 - 01/2005
2	Colchicine FDA LinkGeneric 01/2017 - 01/2016
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 01/2015
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2016 - 01/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2014 - 01/2006
1	GalactosyltransferasesIBA 04/2024
1	Small Interfering RNA (siRNA)IBA 04/2024
1	Itraconazole (Sporanox)FDA LinkGeneric 04/2024
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	Doxycycline (Periostat)FDA LinkGeneric 04/2024
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 08/2023
1	pro-brain natriuretic peptide (1-76)IBA 08/2023
1	Acetylglucosaminidase (NAGase)IBA 08/2023
1	DiureticsIBA 08/2023
1	Neprilysin (Neutral Endopeptidase)IBA 08/2023
1	Surface Antigens (Surface Antigen)IBA 06/2023
1	dapagliflozinIBA 05/2023
1	SymportersIBA 05/2023
1	SodiumIBA 05/2023
1	Glucose (Dextrose)FDA LinkGeneric 05/2023
1	AntithrombinsIBA 02/2023
1	Troponin T (Troponin T1)IBA 02/2023
1	Busulfan (Busulfex)FDA Link 01/2023
1	arginine deiminaseIBA 11/2022
1	Arginine (L-Arginine)FDA Link 11/2022
1	Serine (L-Serine)FDA Link 11/2022
1	pembrolizumabIBA 07/2022
1	COVID-19 VaccinesIBA 05/2022
1	2019-nCoV Vaccine mRNA-1273IBA 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	VaccinesIBA 05/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 11/2021
1	Urea (Carbamide)FDA LinkGeneric 10/2021
1	NitrogenIBA 10/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 09/2019
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 03/2019
1	trans-sodium crocetinate (crocetin)IBA 03/2019
1	CrizotinibIBA 03/2019
1	Anti-Citrullinated Protein AntibodiesIBA 02/2018
1	Rheumatoid FactorIBA 02/2018

Therapy/Procedure

6	Therapeutics 11/2022 - 01/2005
1	Aftercare (After-Treatment) 06/2023
1	Transplantation 01/2023
1	Nephroureterectomy 07/2022
1	Drug Therapy (Chemotherapy) 04/2021
1	Cell Transplantation 04/2021